Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

62804 Press Releases
DateTitleCompany
15 Mar 12 Nuvilex Points Toward Cell Encapsulation Technology Future to Expand Stem Cell Use for Late Stage Cancer Treatments Nuvilex Inc.,
Published by
Business Wire
15 Mar 12 Research and Markets: Rx Marketer's Reference Guide - Essential Reference Tool for Rx Marketers Research and Markets,
Published by
Business Wire
15 Mar 12 Alkermes plc Prices Secondary Offering of 21,000,000 Ordinary Shares Held by Elan Alkermes plc,
Published by
Business Wire
15 Mar 12 Teva Receives FDA Approval for ProAir® HFA (albuterol sulfate) with Dose Counter Teva Respiratory,
Published by
Business Wire
15 Mar 12 Enzo Biochem Schedules Teleconference to Discuss 2012 Second Quarter Results on March 13, 2012 at 8:30 AM E.T. Enzo Biochem Inc.,
Published by
Business Wire
15 Mar 12 Trianz Solutions Releases a White Paper Entitled “Switching EDC Platforms to Rescue In-flight Clinical Trials” Trianz Solutions,
Published by
Business Wire
15 Mar 12 RBCC Moves Forward on Term Sheet with Parkinson’s Drug Therapy Target Rainbow Coral Corp.,
Published by
Business Wire
15 Mar 12 Columbia Laboratories Reports Fourth Quarter and Year-End 2011 Financial Results Columbia Laboratories Inc.,
Published by
Business Wire
15 Mar 12 LifeSciences BC Announces Recipients of the 2012 LifeSciences British Columbia Awards LifeSciences BC,
Published by
Business Wire
15 Mar 12 Lipoderm® Transdermal Is Only Proven Base to Deliver up to Four Medications at Once Professional Compounding Centers of America,
Published by
Business Wire
15 Mar 12 Hi-Tech Pharmacal Acquires a Line of Branded Homeopathic Nasal Spray Products Hi-Tech Pharmacal Co. Inc.,
Published by
Business Wire
15 Mar 12 Hi-Tech Pharmacal Reports Sales of $55.6 Million and EPS of $0.79 for the Third Quarter Ended January 31, 2012 Hi-Tech Pharmacal Co. Inc.,
Published by
Business Wire
15 Mar 12 Boomerang Pharmaceutical Communications Announces Office Move to Accommodate Growth Boomerang Pharmaceutical Communications,
Published by
Business Wire
15 Mar 12 Celgene Completes Acquisition of Avila Therapeutics Celgene Corporation,
Published by
Business Wire
15 Mar 12 Covidien Expands Global Research and Development Presence Covidien,
Published by
Business Wire
15 Mar 12 2nd Antibody Engineering Summit 2012 to Open in Beijing This June CBI China,
Published by
Business Wire
15 Mar 12 AHF Files ‘Citizen’s Petition’ with FDA to ‘Delay or Deny’ Approval of Gilead’s HIV ‘Prevention’ Pill AIDS Healthcare Foundation,
Published by
Business Wire
15 Mar 12 Stratedigm Announces the Launch of The A600 High Throughput Auto Sampler With Flat-6 TechnologyTM Stratedigm,
Published by
Business Wire
15 Mar 12 Pall Corporation Second Quarter Sales Increase 8% Pall Corporation,
Published by
Business Wire
15 Mar 12 Verastem, Inc. Announces Timing for Year-End 2011 Financial Results, Webcast and Conference Call Verastem Inc.,
Published by
Business Wire
15 Mar 12 Alkermes plc Announces a Secondary Offering of 13,900,000 Ordinary Shares Held by Elan Alkermes plc,
Published by
Business Wire
15 Mar 12 Clovis Oncology Announces 2011 Operating Results Clovis Oncology Inc.,
Published by
Business Wire
15 Mar 12 2012 BIO International Convention Super Sessions Focus on Industry Outlook Biotechnology Industry Organization (BIO),
Published by
Business Wire
15 Mar 12 Covidien Peripheral Vascular Stent System Receives FDA Approval Covidien,
Published by
Business Wire
15 Mar 12 New Data Confirm Gilead’s HIV Prevention Pill Fails Says AHF AIDS Healthcare Foundation,
Published by
Business Wire
15 Mar 12 AMAG Pharmaceuticals Announces Preliminary Results from its Phase III Study Evaluating Feraheme Compared to IV Iron Sucrose in Patients with Iron Deficiency Anemia AMAG Pharmaceuticals Inc.,
Published by
Business Wire
15 Mar 12 Affymax Announces Yearend 2011 Financial Results Teleconference and Webcast Affymax Inc.,
Published by
Business Wire
15 Mar 12 InSite Vision to Present at the 24th Annual ROTH Conference InSite Vision Incorporated,
Published by
Business Wire
15 Mar 12 Promedior Secures $21.5 Million in First Closing of Series D Financing to Expand and Advance Pipeline of Pentraxin-2 Therapeutics for Fibrotic Diseases Promedior,
Published by
Business Wire
15 Mar 12 Promedior Receives U.S. Orphan Drug Designation for PRM-151 for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) Promedior Inc.,
Published by
Business Wire
Advertising